Cargando…
Clinical effectiveness of vortioxetine in postcovid syndrome
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789434/ http://dx.doi.org/10.1016/j.nsa.2022.100316 |
_version_ | 1784858953150103552 |
---|---|
author | Vikarenko, M. Vorokhta, Y. Muratova, T. |
author_facet | Vikarenko, M. Vorokhta, Y. Muratova, T. |
author_sort | Vikarenko, M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9789434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97894342022-12-27 Clinical effectiveness of vortioxetine in postcovid syndrome Vikarenko, M. Vorokhta, Y. Muratova, T. Neuroscience Applied Article Published by Elsevier B.V. 2022 2022-12-24 /pmc/articles/PMC9789434/ http://dx.doi.org/10.1016/j.nsa.2022.100316 Text en Copyright © 2022 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Vikarenko, M. Vorokhta, Y. Muratova, T. Clinical effectiveness of vortioxetine in postcovid syndrome |
title | Clinical effectiveness of vortioxetine in postcovid syndrome |
title_full | Clinical effectiveness of vortioxetine in postcovid syndrome |
title_fullStr | Clinical effectiveness of vortioxetine in postcovid syndrome |
title_full_unstemmed | Clinical effectiveness of vortioxetine in postcovid syndrome |
title_short | Clinical effectiveness of vortioxetine in postcovid syndrome |
title_sort | clinical effectiveness of vortioxetine in postcovid syndrome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789434/ http://dx.doi.org/10.1016/j.nsa.2022.100316 |
work_keys_str_mv | AT vikarenkom clinicaleffectivenessofvortioxetineinpostcovidsyndrome AT vorokhtay clinicaleffectivenessofvortioxetineinpostcovidsyndrome AT muratovat clinicaleffectivenessofvortioxetineinpostcovidsyndrome |